About the Event

i4 Connect, the Government-appointed Delivery Partner for the Accelerating Commercialisation service, highly recommends that all entrepreneurs and founders with an interest in the program attend one of our Information Sessions prior to submitting an application.

In recognition of AusBioTech 2022, this session will be delivered in in partnership with the WA Life Sciences Innovation Hub and kindly hosted by Ernst & Young and will focus on emerging technologies in the medical and health care technology sector.

Dr Rob Crombie, Senior Commercialisation Facilitator, will lead the session to give you more information on:

• Why the program exists

• Who is it for

• What kind of support is on offer

• How the service works

Rob is an experienced C-level executive with 25 years in building technology focused businesses in the healthcare space. Rob has founded and transitioned several start-up companies most recently as CEO of clinical-stage QUE Oncology and as the inaugural CEO of ASX-listed cancer drug company Prescient Therapeutics. As former Head of Melbourne Operations for Arana Therapeutics, Rob played a key role in Arana’s successful A$318M acquisition by Cephalon Incorporated. Rob provides specialist advice to companies looking to turn smart innovation into commercial ventures.

---

About Accelerating Commercialisation

Accelerating Commercialisation provides expert guidance and support to help you commercialise novel products, processes and services and find a commercialisation solution that is right for you. Accelerating Commercialisation includes:

• Commercialisation Guidance – guidance and assistance to develop the commercialisation potential of your novel product, process or service

• Accelerating Commercialisation Grants – financial assistance to help commercialise your novel product, process and service.

For more information, visit: https://business.gov.au/grants-and-programs/accelerating-commercialisation

---